Tuesday, November 3, 2015

Must Read (or listen to podcast) from FDA's Dr. Woodcock discussing drug compounding from both a safety and regulatory standpoint, regulatory guidances drafted and submitted to FDA by patient advocacy groups,....

Drug Compounding. 
Dr. Woodcock discusses Drug Compounding from both a safety and regulatory standpoint.
Working with patient advocacy groups. 
Dr. Woodcock discusses regulatory guidances drafted and submitted to FDA by patient advocacy groups.
Looking back and moving forward. As 2015 begins, Dr. Woodcock discusses major events of 2014 and priorities for 2015.

-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)